1-11 of 11
Bernhard Heilmeier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Minimal Residual Disease on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy in the Phase 3 GMMG-HD7 Trial

Elias K. Mai, Hans Salwender, Michael Hundemer, Uta Bertsch, Ema Pozek, Axel Benner, Roland Fenk, Britta Besemer, Christine Hanoun, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Lisa Leypoldt, Bernhard Heilmeier, Stefanie Huhn, Sabine Vogel, Christof Scheid, Igor Wolfgang Blau, Steffen Luntz, Niels Weinhold, Tobias A.W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Evgenii Shumilov, Wolfgang Knauf, Christian Sebastian Michel, Thomas Geer, Hendrik Riesenberg, Christoph Lutz, Marc S. Raab, Martin Hoffmann, Katja C. Weisel, Hartmut Goldschmidt
Journal: Blood
Blood (2024) 144 (Supplement 1): 364.
https://doi.org/10.1182/blood-2024-194768
Published: 2024
Journal Articles

Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Final Progression-Free Survival Analysis of Part 1 of an Open-Label, Multicenter, Randomized, Phase 3 Trial (GMMG-HD7)

Hartmut Goldschmidt, Uta Bertsch, Ema Pozek, Axel Benner, Roland Fenk, Britta Besemer, Christine Hanoun, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Lisa Leypoldt, Bernhard Heilmeier, Stefanie Huhn, Sabine Vogel, Michael Hundemer, Christof Scheid, Igor Wolfgang Blau, Steffen Luntz, Tobias A.W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Evgenii Shumilov, Wolfgang Knauf, Christian Sebastian Michel, Thomas Geer, Hendrik Riesenberg, Christoph Lutz, Marc-Steffen Raab, Martin Hoffmann, Katja C. Weisel, Hans Salwender, Elias K. Mai
Journal: Blood
Blood (2024) 144 (Supplement 1): 769.
https://doi.org/10.1182/blood-2024-193308
Published: 2024
Journal Articles

Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial

Hartmut Goldschmidt, Elias K Mai, Eva Nievergall, Roland Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, Jan Dürig, Roland Schroers, Ivana v. Metzler, Mathias Haenel, Christoph Mann, Anne-Marie Asemissen, Bernhard Heilmeier, Stefanie Huhn, Katharina Kriegsmann, Niels Weinhold, Steffen P. Luntz, Tobias A. W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Cyrus Khandanpour, Wolfgang Knauf, Markus Munder, Thomas Geer, Hendrik Riesenberg, Joerg Thomalla, Martin Hoffmann, Marc-Steffen Raab, Hans Salwender, Katja Weisel
Journal: Blood
Blood (2021) 138 (Supplement 1): 463.
https://doi.org/10.1182/blood-2021-145097
Published: 2021
Journal Articles

Acute Myeloid Leukemia with Isocitrate Dehydrogenases (IDH) 1 and 2 Mutations. a Real-World Study from the European IDH Research Group

Giulia Maggioni, MD, Cristina Astrid Tentori, MD, Maria Teresa Voso, MD, Sonja Heibl, MD, Klaus H. Metzeler, MD, Jan Moritz Middeke, MD, Joana Desterro, Maria Carmo-Fonseca, Erica Travaglino, Paola Fazi, MD, Alfonso Piciocchi, MS, Annika Maria Dufour, PhD, Jordi Esteve, Marta Pratcorona, MD, Valentina Mancini, MD, Federico Lussana, MD, Karsten Spiekermann, Christian Thiede, MD, Friedrich Stolzel, MD, Aida Botelho de Sousa, Mar Tormo, Pamela Acha, Montserrat Arnan, Nicola Fracchiolla, MD, Marcus Hentrich, Christoph Sippel, Bernhard Heilmeier, Marcos Lemos, Albertina Nunes, Sonia Matos, Marina Diaz, Ana Garrido, MD, David Gallardo, MD, Susana Vives, MD, Olga Salamero, Elisabetta Todisco, MDPhD, Claudia Basilico, MD, Francesco Passamonti, Sigrid Machherndl-Spandl, MD, Lisa Pleyer, Jorge Sierra, Francesc Solé, PhD, Matteo Giovanni Della Porta, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-140494
Published: 2020
Journal Articles

High expression of lymphoid enhancer-binding factor-1 ( LEF1 ) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia

Klaus H. Metzeler, Bernhard Heilmeier, Katrin E. Edmaier, Vijay P. S. Rawat, Annika Dufour, Konstanze Döhner, Michaela Feuring-Buske, Jan Braess, Karsten Spiekermann, Thomas Büchner, Maria C. Sauerland, Hartmut Döhner, Wolfgang Hiddemann, Stefan K. Bohlander, Richard F. Schlenk, Lars Bullinger, Christian Buske
Journal: Blood
Blood (2012) 120 (10): 2118–2126.
https://doi.org/10.1182/blood-2012-02-411827
Published: 2012
Includes: Supplemental data
Journal Articles

Acute Myeloid Leukemia and Survival on the Intensive Care Unit (ICU) - Biology- and Treatment-Related Determinants of Outcome - An Analysis of the AML-CG

Bernhard Heilmeier, M.D., Johannes Thudium, Matthias Kochanek, M.D., Christoph Schmid, M.D., Joachim Stemmler, M.D., Karl-Anton Kreuzer, Michael Hallek, M.D., G\)nter Schlimok, M.D., Karsten Spiekermann, MD, Wolfgang Hiddemann, MD, Jan Braess, M.D.
Journal: Blood
Blood (2010) 116 (21): 2166.
https://doi.org/10.1182/blood.V116.21.2166.2166
Published: 2010
Journal Articles

The Vent-Like Homeobox Gene VENTX Promotes Human Myeloid Development and Is Highly Expressed In Acute Myeloid Leukemia

Vijay P. S. Rawat, Ph.D, Natalia Arseni, Farid Ahmed, Medhanie A. Mulaw, Silvia Thoene, Bernhard Heilmeier, M.D., Tim Sadlon, J. D.' Andrea, Wolfgang Hiddemann, MD, S. K Bohlander, MD, Christian Buske, MD, Michaela Feuring-Buskea, MD
Journal: Blood
Blood (2010) 116 (21): 739.
https://doi.org/10.1182/blood.V116.21.739.739
Published: 2010
Journal Articles

High Expression of Lymphoid Enhancer-Binding Factor 1 ( LEF1 ) Is a Novel, Favorable Prognostic Marker in Cytogenetically Normal AML and Is Associated with Upregulation of T-Lymphoid Lineage Markers in AML Blasts.

Klaus H. Metzeler, Bernhard Heilmeier, Konstantin Petropoulos, Maria C. Sauerland, Achim Heinecke, Wolfgang E Berdel, Thomas Buechner, Jan Braess, Karsten Spiekermann, Michaela Feuring-Buske, Wolfgang Hiddemann, Stefan K Bohlander, Christian Buske
Journal: Blood
Blood (2009) 114 (22): 398.
https://doi.org/10.1182/blood.V114.22.398.398
Published: 2009
Journal Articles

Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation – Follow up

Bernhard Heilmeier, Nadine Stowasser, Gerard Socie, MD, PhD, Maria Teresa van Lint, Andre Tichelli, Nina Salooja, Elke Nekolla, Per T. Ljungman, MD, PhD, Niels Jacobsen, Marie van Weel, Johanna Tischer, Georg Ledderose, Theodor M. Fliedner, Hans-Jochem Kolb
Journal: Blood
Blood (2008) 112 (11): 453.
https://doi.org/10.1182/blood.V112.11.453.453
Published: 2008
Journal Articles

Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia

Vijay P. S. Rawat, Silvia Thoene, Vegi M. Naidu, Natalia Arseni, Bernhard Heilmeier, Klaus Metzeler, Konstantin Petropoulos, Aniruddha Deshpande, Leticia Quintanilla-Martinez, Stefan K. Bohlander, Karsten Spiekermann, Wolfgang Hiddemann, Michaela Feuring-Buske, Christian Buske
Journal: Blood
Blood (2008) 111 (1): 309–319.
https://doi.org/10.1182/blood-2007-04-085407
Published: 2008
Includes: Supplemental data
Journal Articles

Ectopic Expression of CDX2 Perturbs HOX Gene Expression in Murine Progenitors Depending on Its N-Terminal Transactivation Domain and Is Closely Correlated with Deregulated HOX Gene Expression in Human Acute Myeloid Leukemia.

Vijay P.S. Rawat, PhD, Silvia Thoene, M.Sc, Vegi M. Naidu, M.Sc, Natalia Arseni, Ph.D., Bernhard Heilmeier, M.D., Klaus Metzeler, M.D., Konstantin Petropoulos, M.Sc, Aniruddha Deshpande, Ph.D., Leticia Quintanilla-Martinez, M.D., Stefan Bohlander, M.D., Karsten Spiekermann, M.D., Wolfgang Hiddemann, M.D., Michaela Feuring-Buske, M.D., Christian Buske, M.D.
Journal: Blood
Blood (2007) 110 (11): 2125.
https://doi.org/10.1182/blood.V110.11.2125.2125
Published: 2007